Merdol Ibrahim

Updated UK Recommendations for HER2 assessment in breast cancer

Emad A. Rakha, Sarah E. Pinder, John M.S. Bartlett et al. · Journal of Clinical Pathology · 2014 · 259 citations · Full text

Medicine, Molecular Medicine, Oncology +13

Standardization of Negative Controls in Diagnostic Immunohistochemistry

Emina Torlakovic, Glenn Francis, J. R. Garratt et al. · Applied immunohistochemistry & molecular morphology · 2014 · 135 citations · Full text

Medicine, Pathology, Diagnostic Pathology +12

HER2 testing in the UK: recommendations for breast and gastric in-situ hybridisation methods

J. M. S. Bartlett, Jane Starczynski, Neil Atkey et al. · Journal of Clinical Pathology · 2011 · 78 citations

Medicine, Oncology, Pathology +14

Breast cancer biomarkers in clinical testing: analysis of a UK national external quality assessment scheme for immunocytochemistry and in situ hybridisation database containing results from 199 300 patients

Andrew Dodson, Suzanne Parry, Merdol Ibrahim et al. · The Journal of Pathology Clinical Research · 2018 · 66 citations · Full text

Medicine, Oncology, Pathology +15

Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine. Part 3: Technical Validation of Immunohistochemistry (IHC) Assays in Clinical IHC Laboratories

Emina Torlakovic, Carol C. Cheung, Corrado D’Arrigo et al. · Applied immunohistochemistry & molecular morphology · 2017 · 64 citations

Medicine, Biotechnology, Method Validation +15